Neurosyphilis

Neurological Disorders: Course and Treatment: Second Edition

Volumn , Issue , 2003, Pages 575-582

  Prange, H ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649384704     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012125831-3/50241-0     Document Type: Chapter

References (31)

1. Centers for Disease Control and Prevention 1998 Guidelines for treatment of sexually transmitted disease. Morb. Morbid. Wkly. Rep. 1998, 47:1-111.
2. National guideline for the management of late syphilis. Sex Transm Inf 1999, 75(Suppl):S34-S37. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
3. Chesney A.M., Kemp J.E. Incidence of Spirochaeta pallida in cerebrospinal fluid during early stage of syphilis. JAMA 1924, 83:1725-1728.
4. Clark E.G., Danbolt N. The Oslo study of the natural course of untreated syphilis. Med. Clin. North Am. 1964, 48:613-623.
5. Engel S., Krause H., Metz D. Liquorbefunde bei Frûhsyphilis. Dermatol. Monatsschr. 1980, 166:223-228.
6. Felgenhauer K., Lûer W., Weber T., et al. CSF changes in chronic HIV encephalitis and opportunistic infections of the brain. Advances in Neurology 1990, 229-237. Elsevier Science, Amsterdam. J.S. Chopra (Ed.).
7. Fox P.A., Hawkin D.A., Dawson D. Dementia following an acute presentation of menigovascular neurosyphilis in an HIV-1-positive patient. AIDS 2000, 14:2062-2063.
8. Goh B.T., Smith G.W., Samarasinghe L., et al. Penicillin concentrations in serum and cerebrospinal fluid after intramuscular injection of aqueous procaine penicillin 0.6 MU with and without probenecid. Br. J. Vener. Dis. 1984, 60:371-373.
9. Gordon S.M., Eaton M.E., George R., et al. The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N. Engl. J. Med. 1994, 331:1469-1473.
10. Hook E.W., Marra C. Acquired syphilis in adults. N. Engl. J. Med. 1992, 326:1060-1069.
11. Horowitz H.W., Valsamis M.P., Whicher V., et al. Brief report: Cerebral syphilitic gumma confirmed by polymerase chain reaction in a man with HIV infection. N. Engl. J. Med. 1994, 331:1488-1491.
12. Idsoe O., Guthe T., Willcox R.R. Penicillin in the treatment of syphilis: The experience of three decades. Bull. World Health Org. 1972, 47(Suppl. 1):1-68.
13. Korting H.C., Walther D., Riethmûller U., et al. Comparative in vivo susceptibility of Treponema pallidum to ceftizoxime, ceftriaxone and penicillin G. Chemotherapy 1986, 32:352-355.
14. Löwhagen G.B., Andersson M., Blomstrand C., et al. Central nervous system involvement in early syphilis. Acta Derm. Venereol. (Stockholm) 1983, 63:409-417.
15. Lukehart S.A. Hook E.W., Baker-Zander S.A., et al. Invasion of the central nervous system by Treponema pallidum: Implication for diagnosis and treatment. Ann. Intern. Med. 1988 ,109:855-862.
16. Marra C.M., Gary D.W., Kuypers, et al. Diagnosis of neurosyphilis in patients infected with human immunodeficiency virus type 1. J. Infect. Dis. 1996, 174:219-221.
17. Marra C.M., Boutin P., McArthur J.C., et al. A pilot study evaluating cetriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin. Infect. Dis. 2000, 30:540-544.
18. Mills C.H. Routine examination of the cerebrospinal fluid in syphilis. Br. Med. J. 1927, 2:527-532.
19. Mohr J.A., Griffiths W., Jackson R., et al. Neurosyphilis and penicillin levels in cerebrospinal fluid. JAMA 1976, 236:2208-2209.
20. Moore J.E., Hopkins H.H. Asymptomatic neurosyphilis. VI. The prognosis of early and late asymptomatic neurosyphilis. JAMA 1930, 95:1637-1641.
21. Nau R., Prange H.W., Muth P., et al. Passage of cefotaxime and ceftriaxone into the cerebrospinal fluid of patients with uninflamed meninges. Antimicrob. Agents Chemother. 1983, 27:1518-1524.
22. Prange H., Moskophidis M., Schipper H.I., et al. Relationship between neurological features and intrathecal synthesis of IgG antibodies to Treponema pallidum in untreated and treated human neurosyphilis. J. Neurol. 1983, 230:241-252.
23. Prange H.W., Robis-Seidenschwanz I. Zur Evaluierung serologischer Aktivitätskriterien bei Neurosyphilis. Verh. Dtsch. Ges. Neurol. Bd. 1994/1995, 8:789-791.
24. Quinn T.C., Bender B. Sexually transmitted diseases. The Principles and Practice of Medicine 1988, 661-663. Appleton & Lange, Norwalk, C.T. 22nd ed. A.M. Harvey, R.J. Johns, McKusick (Eds.).
25. Reiber H., Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum. Clin. Chem. 1991, 37:1153-1160.
26. Rein M.F. Treatment of neurosyphilis. JAMA 1981, 246:2613.
27. Roose K.L. Neurosyphilis. Semin. Neurol. 1992, 112:209-212.
28. Rowland L.P. Spriochete infections: Neurosyphilis. Merritt's Textbook of Neurology 1995, 200-208. Williams & Wilkins, Baltimore. 9th ed. L.P. Rowland (Ed.).
29. Secher L., Weismann K., Kobayasi T. Treponema pallidum in peripheral nerve tissue of syphilitic chancres. Acta Derm. Venereol. (Stockholm) 1982, 62:407-411.
30. Volles E., Ritter G. Zur Penizillin-Behandlung der Neurolues unter pharmakokinetischem Aspekt. Z. Neurol. 1974, 206:235-242.
31. Wile U.J., Hasley C.K. Involvement of nervous system during primary stage of syphilis. JAMA 1921, 76:8-9.